These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 24632828

  • 1. CCR2 gene deletion and pharmacologic blockade ameliorate a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome.
    Yuan F, Yosef N, Lakshmana Reddy C, Huang A, Chiang SC, Tithi HR, Ubogu EE.
    PLoS One; 2014; 9(3):e90463. PubMed ID: 24632828
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Monocyte chemoattractant protein 1 and chemokine receptor CCR2 productions in Guillain-Barré syndrome and experimental autoimmune neuritis.
    Orlikowski D, Chazaud B, Plonquet A, Poron F, Sharshar T, Maison P, Raphaël JC, Gherardi RK, Créange A.
    J Neuroimmunol; 2003 Jan; 134(1-2):118-27. PubMed ID: 12507779
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Development of a major histocompatibility complex class II conditional knockout mouse to study cell-specific and time-dependent adaptive immune responses in peripheral nerves.
    Ubogu EE, Conner JA, Wang Y, Yadav D, Saunders TL.
    Muscle Nerve; 2024 Sep; 70(3):420-433. PubMed ID: 38922958
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats.
    Zou LP, Pelidou SH, Abbas N, Deretzi G, Mix E, Schaltzbeerg M, Winblad B, Zhu J.
    J Neuroimmunol; 1999 Aug 03; 98(2):168-75. PubMed ID: 10430050
    [Abstract] [Full Text] [Related]

  • 8. CX3CR1 But Not CCR2 Expression Is Required for the Development of Autoimmune Peripheral Neuropathy in Mice.
    Oladiran O, Shi XQ, Fournier S, Zhang J.
    Front Immunol; 2021 Aug 03; 12():720733. PubMed ID: 34484228
    [Abstract] [Full Text] [Related]

  • 9. P2X7 receptor antagonists modulate experimental autoimmune neuritis via regulation of NLRP3 inflammasome activation and Th17 and Th1 cell differentiation.
    Xie Y, Han R, Li Y, Li W, Zhang S, Wu Y, Zhao Y, Liu R, Wu J, Jiang W, Chen X.
    J Neuroinflammation; 2024 Mar 25; 21(1):73. PubMed ID: 38528529
    [Abstract] [Full Text] [Related]

  • 10. The effects of vasoactive intestinal peptide in the rat model of experimental autoimmune neuritis and the implications for treatment of acute inflammatory demyelinating polyradiculoneuropathy or Guillain-Barré syndrome.
    Jiao H, Ren H.
    Drug Des Devel Ther; 2018 Mar 25; 12():3817-3824. PubMed ID: 30464413
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The critical role of IL-12p40 in initiating, enhancing, and perpetuating pathogenic events in murine experimental autoimmune neuritis.
    Bao L, Lindgren JU, van der Meide P, Zhu Sw, Ljunggren HG, Zhu J.
    Brain Pathol; 2002 Oct 25; 12(4):420-9. PubMed ID: 12408228
    [Abstract] [Full Text] [Related]

  • 14. The therapeutic effects of ginkgolides in Guillain-Barré syndrome and experimental autoimmune neuritis.
    Li C, Liu S, Aerqin Q, Shen D, Wu X, Liu K.
    J Clin Neurosci; 2021 May 25; 87():44-49. PubMed ID: 33863532
    [Abstract] [Full Text] [Related]

  • 15. Improved outcome of EAN, an animal model of GBS, through amelioration of peripheral and central inflammation by minocycline.
    Zhang ZY, Zhang Z, Fauser U, Schluesener HJ.
    J Cell Mol Med; 2009 Feb 25; 13(2):341-51. PubMed ID: 18400050
    [Abstract] [Full Text] [Related]

  • 16. Pain hypersensitivity in rats with experimental autoimmune neuritis, an animal model of human inflammatory demyelinating neuropathy.
    Moalem-Taylor G, Allbutt HN, Iordanova MD, Tracey DJ.
    Brain Behav Immun; 2007 Jul 25; 21(5):699-710. PubMed ID: 17005365
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inflammation and proinflammatory cytokine production, but no demyelination of facial nerves, in experimental autoimmune neuritis in Lewis rats.
    Zhu W, Mix E, Zhu J.
    J Neuroimmunol; 2003 Jul 25; 140(1-2):97-101. PubMed ID: 12864976
    [Abstract] [Full Text] [Related]

  • 20. Failure of intravenous immunoglobulin (IVIg) therapy in experimental autoimmune neuritis (EAN) of the Lewis rat.
    Enders U, Toyka KV, Hartung HP, Gold R.
    J Neuroimmunol; 1997 Jun 25; 76(1-2):112-6. PubMed ID: 9184640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.